Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Renata Sanovic"'
Autor:
Carina Grafetstätter, Josef Thalhamer, Johanna Prossegger, Arnulf Hartl, Christina Pichler, Herbert Braunschmid, Penelope Hahne, Renata Sanovic
Publikováno v:
Allergy, Asthma & Immunology Research
Purpose Several studies over the past 4 decades have indicated a significant reduction in house dust mite (HDM) and HDM allergen concentration in areas higher than 1,500 m above sea level. These have served as basis of allergen avoidance therapies fo
Autor:
Arnulf Hartl, Markus Ritter, Amina Selimovic, P. Kolarž, Josef Thalhamer, Heidemarie Dobias, Isidor Huttegger, Renata Sanovic, Angelika Moder, Martin Gaisberger
Publikováno v:
The Journal of asthma : official journal of the Association for the Care of Asthma. 49(8)
Ionized water aerosols have been suggested to exert beneficial health effects on pediatric allergic asthma. Their effect was evaluated in a randomized controlled clinical trial as part of a summer asthma camp.Asthmatic allergic children (n = 54) spen
Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma
Publikováno v:
Photodiagnosis and photodynamic therapy. 8(4)
Summary Background Successful tumor eradication with photodynamic therapy (PDT) in vivo depends on the optimal combination of treatment parameters. (Low-dose) PDT may additionally induce antitumoral immune responses. Since the naturally occurring hyp
Autor:
Gertraud Weiss, Bernd Lamprecht, Fikreta Grabcanovic-Musija, Romana Mikes, Martin Gaisberger, Michael Studnicka, Arnulf Hartl, Heidi Dobias, Renata Sanovic
Publikováno v:
A29. NOVEL INSIGHTS INTO LUNG MECHANICS IN HEALTH AND DISEASE.
Publikováno v:
International journal of oncology. 35(4)
Hypericin is used as a powerful naturally occurring photosensitizer in photodynamic therapy (PDT). Activated by visible light, it kills tumour cells and tissues via generation of reactive oxygen species (ROS). Depending on the protocol, apoptotic cel
Publikováno v:
International Journal of Oncology.
The photosensitizer protoporphyrin IX, endogenously accumulated from the precursor aminolevulinic acid (ALA) as well as other less photodynamically effective intermediates, is a successful agent in photodynamic therapy. Despite encouraging clinical r
Publikováno v:
International journal of oncology. 30(5)
The photosensitizer protoporphyrin IX, endogenously accumulated from the precursor aminolevulinic acid (ALA) as well as other less photodynamically effective intermediates, is a successful agent in photodynamic therapy. Despite encouraging clinical r
Publikováno v:
Europe PubMed Central
ResearcherID
Scopus-Elsevier
ResearcherID
Scopus-Elsevier
The photosensitizer protoporphyrin IX, endogenously accumulated from the precursor aminolevulinic acid, is a successful agent in photodynamic tumor therapy. In spite of encouraging clinical results, the basic mechanisms leading to cell death are not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e80b591266bed74b83c639ea5e0e2e7a
http://europepmc.org/abstract/med/12429988
http://europepmc.org/abstract/med/12429988